TY  - GEN
AU  - Dutzer,D
AU  - Nasser,Y
AU  - Berger,A E
AU  - Roblin,X
AU  - Paul,S
TI  - Letter: new thresholds need to be defined when using point of care assays to monitor infliximab trough levels in IBD patients
SN  - 1365-2036
PY  - 2019///0729
KW  - Colitis, Ulcerative
KW  - Gastrointestinal Agents
KW  - Humans
KW  - Inflammatory Bowel Diseases
KW  - Infliximab
KW  - Point-of-Care Systems
N1  - Publication Type: Letter; Comment
UR  - https://doi.org/10.1111/apt.14645
ER  -